生物钟
下调和上调
昼夜节律
代谢途径
体内
基因沉默
化学
细胞生物学
焊剂(冶金)
癌细胞
线粒体
时辰疗法(睡眠期)
生物
体外
内生
癌症研究
DNA损伤
肿瘤微环境
转染
癌症
细胞凋亡
药理学
细胞
细胞毒性T细胞
流出
细胞周期检查点
程序性细胞死亡
细胞毒性
新陈代谢
作者
Wenxian Zhang,Zhiyuan Feng,Zhe Feng,Rui Lian,Zheng Liu,Jingjing Zhang
出处
期刊:ACS Nano
[American Chemical Society]
日期:2025-10-10
卷期号:19 (41): 36701-36717
被引量:17
标识
DOI:10.1021/acsnano.5c12641
摘要
Despite the promise of cuproptosis in antitumor therapy, developing strategies to enhance its therapeutic efficacy within the tumor microenvironment remains a challenge. Inspired by the chronotherapy that manipulate circadian rhythms to enhance drug effectiveness, herein we report for a CRISPR-customized copper-DNA nanoplatform (Cu-RNP) that synergistically induces multimodal cell death, including potentiated cuproptosis, by manipulating circadian and metabolic pathways. Cu-RNP integrates coordination-driven self-assembly of Cu 2+ -DNA nanospheres with Cas13d/crRNA ribonucleoproteins targeting BMAL1. Upon cellular internalization, the acidic and reducing endo/lysosomal environment triggers Cu-RNP disassembly, releasing RNP to silence BMAL1 and disrupt circadian oscillations, leading to WEE 1 downregulation and p 21 upregulation, thereby inducing apoptosis. Simultaneously, liberated Cu 2+ generates cytotoxic hydroxyl radicals for chemodynamic therapy (CDT) and concurrently depletes GSH, promoting mitochondrial copper overload for cuproptosis. Importantly, we demonstrate that silencing BMAL1 disrupts circadian rhythms, inhibits glycolysis, enhances mitochondrial respiration, and redirects metabolic flux to the TCA cycle, thereby amplifying the cell’s vulnerability to copper-induced cuproptosis. In vitro and in vivo results demonstrate that Cu-RNP sensitizes cancer cells to cuproptosis and elicit strong antitumor response through the synergistic combination of cuproptosis, CDT, apoptosis, and circadian-metabolic modulation. This study demonstrates a mechanistic link between BMAL1-regulated circadian rhythms and cuproptosis sensitivity, suggesting a potential treatment strategy for multimodal, cuproptosis-potentiating cancer therapies.
科研通智能强力驱动
Strongly Powered by AbleSci AI